Search research articles
Contact Us
Filters
Showing results (371-380 of 491) with videos related to
Page
of 50
Sort By:
American Journal of Clinical Dermatology
|
March 31, 2018
Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.
American Journal of Clinical Dermatology
|
January 12, 2017
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.
American Journal of Clinical Dermatology
|
October 20, 2022
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies
Lisa Bloudek, Lawrence F Eichenfield, Jonathan I Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 11, 2023
Implementing well-being in the management of psoriasis: An expert recommendation
Rachel Sommer, Ulrich Mrowietz, Kristian Gaarn Du Jardin, et al.
Dermatology and Therapy
|
September 16, 2024
Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis
Matthias Augustin, Alice B Gottlieb, Mark Lebwohl, et al.
Journal of Wound Care
|
February 15, 2020
Efficacy of MMP-inhibiting wound dressings in the treatment of chronic wounds: a systematic review
Joachim Dissemond, Matthias Augustin, Michael Dietlein, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 7, 2018
What is psoriasis? - Perception and assessment of psoriasis among the German population
Rachel Sommer, Ulrich Mrowietz, Marc Alexander Radtke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 7, 2018
Was ist Schuppenflechte? - Wahrnehmung und Bewertung der Psoriasis in der deutschen Bevölkerung
Rachel Sommer, Ulrich Mrowietz, Marc Alexander Radtke, et al.
Life (Basel, Switzerland)
|
October 27, 2022
Switching from Adalimumab Originator to Biosimilar in Patients with Hidradenitis Suppurativa Results in Losses of Response-Data from the German HS Registry HSBest
Natalia Kirsten, Frenz Ohm, Kathrin Gehrdau, et al.
Journal of Drugs in Dermatology : JDD
|
April 14, 2021
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies
Melinda J Gooderham, Boni Elewski, Matthias Augustin, et al.
Page
of 50
Search research articles
Search
Showing results (371-380 of 491) with videos related to
Sort By:
Page
of 50
American Journal of Clinical Dermatology
|
March 31, 2018
Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.
American Journal of Clinical Dermatology
|
January 12, 2017
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.
American Journal of Clinical Dermatology
|
October 20, 2022
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies
Lisa Bloudek, Lawrence F Eichenfield, Jonathan I Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 11, 2023
Implementing well-being in the management of psoriasis: An expert recommendation
Rachel Sommer, Ulrich Mrowietz, Kristian Gaarn Du Jardin, et al.
Dermatology and Therapy
|
September 16, 2024
Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis
Matthias Augustin, Alice B Gottlieb, Mark Lebwohl, et al.
Journal of Wound Care
|
February 15, 2020
Efficacy of MMP-inhibiting wound dressings in the treatment of chronic wounds: a systematic review
Joachim Dissemond, Matthias Augustin, Michael Dietlein, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 7, 2018
What is psoriasis? - Perception and assessment of psoriasis among the German population
Rachel Sommer, Ulrich Mrowietz, Marc Alexander Radtke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 7, 2018
Was ist Schuppenflechte? - Wahrnehmung und Bewertung der Psoriasis in der deutschen Bevölkerung
Rachel Sommer, Ulrich Mrowietz, Marc Alexander Radtke, et al.
Life (Basel, Switzerland)
|
October 27, 2022
Switching from Adalimumab Originator to Biosimilar in Patients with Hidradenitis Suppurativa Results in Losses of Response-Data from the German HS Registry HSBest
Natalia Kirsten, Frenz Ohm, Kathrin Gehrdau, et al.
Journal of Drugs in Dermatology : JDD
|
April 14, 2021
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies
Melinda J Gooderham, Boni Elewski, Matthias Augustin, et al.
Page
of 50